申请人:TES Pharma S.r.l.
公开号:US20210323942A1
公开(公告)日:2021-10-21
The present disclosure relates to compounds capable of modulating the activity of NR2F6. The compounds of the disclosure may be used in methods for the prevention and/or the treatment of diseases and disorders associated with modulating NR2F6 activity.